• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.

作者信息

Bertz Hartmut, Drognitz Kathrin, Lübbert Michael

机构信息

Division of Hematology, Oncology and Stem Cell Transplantation, University Clinic Department of Internal Medicine I, 79106, Freiburg, Germany,

出版信息

Ann Hematol. 2014 Jan;93(1):165-7. doi: 10.1007/s00277-013-1854-6. Epub 2013 Aug 15.

DOI:10.1007/s00277-013-1854-6
PMID:23949313
Abstract
摘要

相似文献

1
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.泊沙康唑与氟康唑在接受急性髓系白血病化疗患者中的抗真菌预防及真菌学诊断效果无差异，仅成本有别：一项为期1年的“真实世界”评估
Ann Hematol. 2014 Jan;93(1):165-7. doi: 10.1007/s00277-013-1854-6. Epub 2013 Aug 15.
2
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.氟康唑、泊沙康唑和伏立康唑用于接受首次巩固化疗的急性髓系白血病患者抗真菌预防的药物经济学评价。
J Antimicrob Chemother. 2013 Jul;68(7):1669-78. doi: 10.1093/jac/dkt068. Epub 2013 Mar 13.
3
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.SEIFEM 2010-E：泊沙康唑用于接受诱导化疗的急性髓系白血病患者抗真菌预防的经济学评价
Leuk Lymphoma. 2017 Dec;58(12):2859-2864. doi: 10.1080/10428194.2017.1318438. Epub 2017 May 16.
4
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.荷兰高危中性粒细胞减少患者中泊沙康唑与标准唑类预防用药的经济学评价
Eur J Haematol. 2008 Dec;81(6):467-74. doi: 10.1111/j.1600-0609.2008.01141.x.
5
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.泊沙康唑与氟康唑或伊曲康唑预防瑞典高危中性粒细胞减少患者侵袭性真菌感染的经济学评价
Clin Drug Investig. 2014 Jul;34(7):483-9. doi: 10.1007/s40261-014-0199-9.
6
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.泊沙康唑与氟康唑预防用药相比，侵袭性真菌病减少，但对总生存期无影响：一项针对接受急性髓系白血病/骨髓增生异常综合征诱导治疗患者的回顾性队列研究。
Eur J Haematol. 2016 Feb;96(2):175-80. doi: 10.1111/ejh.12565. Epub 2015 May 6.
7
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].泊沙康唑预防意大利急性髓系白血病或骨髓增生异常综合征中性粒细胞减少患者侵袭性真菌感染的经济学评价
Infez Med. 2010 Jun;18(2):91-103.
8
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.泊沙康唑与氟康唑或伊曲康唑作为高危血液病患者一线抗真菌预防用药的成本效益分析：一项倾向评分匹配分析
Clin Ther. 2015 Sep;37(9):2019-27. doi: 10.1016/j.clinthera.2015.06.014. Epub 2015 Jul 15.
9
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.急性髓系白血病一线化疗期间的泊沙康唑预防：单中心真实经验。
Haematologica. 2012 Apr;97(4):560-7. doi: 10.3324/haematol.2011.053058. Epub 2011 Nov 18.
10
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.泊沙康唑与氟康唑或伊曲康唑预防急性髓系白血病或骨髓增生异常综合征患者侵袭性真菌病的疗效比较：亚洲一家教学医院的成本效益分析
J Med Econ. 2016;19(1):77-83. doi: 10.3111/13696998.2015.1094477. Epub 2015 Oct 8.

引用本文的文献

1
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.低剂量氟康唑作为异基因造血干细胞移植患者一种有用且安全的预防选择。
Cancer Med. 2024 Feb;13(3):e6815. doi: 10.1002/cam4.6815. Epub 2024 Jan 11.
2
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).血液系统恶性肿瘤患者侵袭性真菌感染的一级预防：德国血液学和医学肿瘤学会（DGHO）传染病工作组（AGIHO）2017年推荐更新版
Ann Hematol. 2018 Feb;97(2):197-207. doi: 10.1007/s00277-017-3196-2. Epub 2017 Dec 7.
3
Therapeutic Drug Monitoring of Posaconazole: an Update.泊沙康唑的治疗药物监测：最新进展
Curr Fungal Infect Rep. 2016;10:51-61. doi: 10.1007/s12281-016-0255-4. Epub 2016 May 7.
4
Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.一名淋巴瘤患者的 Lichtheimia 感染：病例报告及现有诊断工具的简要综述
Mycopathologia. 2016 Aug;181(7-8):561-6. doi: 10.1007/s11046-016-0010-y. Epub 2016 Apr 26.
5
A Single Center Experience for Antifungal Prophylaxis in Patients with Acute Myelogenous Leukemia.急性髓系白血病患者抗真菌预防的单中心经验
Indian J Hematol Blood Transfus. 2015 Sep;31(3):339-45. doi: 10.1007/s12288-014-0472-3. Epub 2014 Nov 2.
6
Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.泊沙康唑口服混悬液在急性髓系白血病诱导化疗期间进行抗真菌预防的疗效
J Cancer Res Clin Oncol. 2015 Sep;141(9):1661-8. doi: 10.1007/s00432-015-1962-x. Epub 2015 Mar 24.